Haisco Pharmaceutical Group Co., Ltd. is a renowned pharmaceutical company engaged in the research, development, production, and distribution of medical drugs. Its primary function is to provide a wide range of pharmaceutical products that address various therapeutic areas, enhancing healthcare solutions for patients worldwide. Haisco specializes in creating value-added generic drugs, focusing on fields such as oncology, central nervous system disorders, and cardio-cerebrovascular diseases. The company is deeply involved in the Chinese healthcare sector, with ambitions to expand its reach globally.

With a dedication to innovation and quality, Haisco invests significantly in pharmaceutical R&D, leveraging advanced technologies to develop effective medicinal solutions. Its products are distributed through a network of hospitals, pharmacies, and medical institutions, underscoring its critical role in the pharmaceutical supply chain. As an influential player in the pharmaceutical industry, Haisco contributes to the accessibility and advancement of healthcare, supporting the treatment needs of a diverse patient population. The company's efforts are pivotal in meeting healthcare demands, ensuring the availability of essential medicines, and promoting public health initiatives across its operating regions.